跳至主要内容
临床试验/IRCT20180610040049N4
IRCT20180610040049N4已完成3 期

The comparison of effectiveness of Tanacetum parthenium (L) Sch. syrups on clinical and paraclinical features of inpatients infected with 2019 novel coronavirus COVID-19, Parallel randomized trial

Ghoum University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 70 years(—)
性别
All

入选标准

  • Having informed consent to participate in the study
  • The definitive diagnosis of COVID-19
  • Failure to attend another clinical trial simultaneously

排除标准

  • Patient's willingness to use other therapies
  • Alzheimer's patients

研究者

发起方
Ghoum University of Medical Sciences

相似试验